OpenAI Launches gpt‑rosalind‑discovery as AI Drug Discovery Gains $8.4 B Investment, While Virtual Trial Simulations Boost Pharma Decision‑Making
Key developments: OpenAI has quietly added a new life‑sciences model, gpt‑rosalind‑discovery, to its API pricing page, positioning it as a dedicated drug‑discovery tool. The model appears beside the existing gpt‑rosalind‑research offering and is priced the same, suggesting a…
Continue reading OpenAI Launches gpt‑rosalind‑discovery as AI Drug Discovery Gains $8.4 B Investment, While Virtual Trial Simulations Boost Pharma Decision‑Making